Bank of America’s Oric Pharmaceuticals ORIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.03M | Buy |
298,442
+38,641
| +15% | +$392K | ﹤0.01% | 3692 |
|
|
2025
Q1 | $1.45M | Buy |
259,801
+147,281
| +131% | +$822K | ﹤0.01% | 4142 |
|
|
2024
Q4 | $908K | Buy |
112,520
+28,570
| +34% | +$231K | ﹤0.01% | 4317 |
|
|
2024
Q3 | $860K | Sell |
83,950
-192,539
| -70% | -$1.97M | ﹤0.01% | 4366 |
|
|
2024
Q2 | $1.95M | Buy |
276,489
+75,367
| +37% | +$533K | ﹤0.01% | 3796 |
|
|
2024
Q1 | $2.77M | Buy |
201,122
+95,432
| +90% | +$1.31M | ﹤0.01% | 3531 |
|
|
2023
Q4 | $972K | Sell |
105,690
-27,416
| -21% | -$252K | ﹤0.01% | 4160 |
|
|
2023
Q3 | $805K | Sell |
133,106
-12,445
| -9% | -$75.3K | ﹤0.01% | 4172 |
|
|
2023
Q2 | $1.13M | Buy |
145,551
+20,314
| +16% | +$158K | ﹤0.01% | 3937 |
|
|
2023
Q1 | $714K | Buy |
125,237
+92,457
| +282% | +$527K | ﹤0.01% | 4397 |
|
|
2022
Q4 | $193K | Buy |
32,780
+3,262
| +11% | +$19.2K | ﹤0.01% | 5206 |
|
|
2022
Q3 | $95K | Buy |
29,518
+4,661
| +19% | +$15K | ﹤0.01% | 5549 |
|
|
2022
Q2 | $111K | Sell |
24,857
-5,484
| -18% | -$24.5K | ﹤0.01% | 5641 |
|
|
2022
Q1 | $162K | Sell |
30,341
-47,522
| -61% | -$254K | ﹤0.01% | 5829 |
|
|
2021
Q4 | $1.15M | Buy |
77,863
+64,889
| +500% | +$954K | ﹤0.01% | 4401 |
|
|
2021
Q3 | $271K | Sell |
12,974
-6,840
| -35% | -$143K | ﹤0.01% | 5260 |
|
|
2021
Q2 | $351K | Buy |
19,814
+9,515
| +92% | +$169K | ﹤0.01% | 4954 |
|
|
2021
Q1 | $252K | Buy |
10,299
+7,646
| +288% | +$187K | ﹤0.01% | 5222 |
|
|
2020
Q4 | $89K | Buy |
2,653
+1,002
| +61% | +$33.6K | ﹤0.01% | 5307 |
|
|
2020
Q3 | $41K | Sell |
1,651
-11,709
| -88% | -$291K | ﹤0.01% | 5437 |
|
|
2020
Q2 | $451K | Buy |
+13,360
| New | +$451K | ﹤0.01% | 4185 |
|